A series of N-phenyl-2-aza-spiro[4.5]
decane-1,3-diones [III-VIIII] structurally related to the previously described N-phenyl-3-arylpyrrolidine-2,5-dione (11) was synthesized and tested for their
anticonvulsant activity in the maximum electroshock seizure (MES) and
metrazole seizure threshold (sc. MET) tests. The most potent of the series were N-(2-methylphenyl)-2-aza-spiro[4.5]
decane-1,3-dione [III] and N-(3-methylphenyl)-2-aza-spiro [4.5]
decane-1,3-dione [IV], which inhibited
seizures in the MES and sc.MET tests. On the other hand, as a preliminary assay we synthesized and tested for the
anticonvulsant activity a new N-substituted 8-phenyl-2-aza-spiro[4.5]
decane-1,3-dione, containing either a benzyl or a cyclohexyl moiety [IX-XII] at the
nitrogen atom. The obtained results showed that the presence and position of the methyl group in the aryl ring [III, IV], as well as an
cyclohexane moiety [XI, XIII connected with the
imide nitrogen atom, played the essential role for
anticonvulsant activity.